TEL AVIV — Teva Pharmaceutical Industries expects to finalize an opioid settlement in the United States by year-end and start paying in 2023, its chief executive said on Sunday, while confirming he was unlikely to renew his contract next year. After years of negotiations, Israel-based Teva in July proposed a $4.35 billion nationwide settlement – [……
>> CLICK HERE << Get A FREE Copy Of My Special Report
“Can Your Retirement Survive” Today!
We Even Pay For Shipping & Handling!
|Click Here To Request Your FREE IRS Loophole Guide|
This post contains affiliate links. If you use these links to buy something we may earn a commission. Thanks.”